Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia
08:00am, Tuesday, 10'th Jun 2025
NEUCHATEL, Switzerland--(BUSINESS WIRE)-- #Masimo--A new study found that EEG-guided anesthesia using Masimo SedLine® improved anesthesia administration in children undergoing surgery.
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
06:59pm, Wednesday, 04'th Jun 2025
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers of Masimo Corpor
Masimo to Present in the Jefferies Global Healthcare Conference
09:00am, Tuesday, 27'th May 2025
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 1:25 p.m. Easter
MASI INVESTIGATION ALERT: Johnson Fistel PLLP Investigates the Directors and Officers of Masimo Corporation for Breach of Fiduciary Duties
09:07am, Wednesday, 21'st May 2025
SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a shareholder rights law firm, announces it is investigating potential breaches of fiduciary duties by certain directors and officers
Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:45pm, Thursday, 08'th May 2025
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
MASI Stock Slips Despite Q1 Earnings and Revenue Beat, Margins Expand
01:30pm, Wednesday, 07'th May 2025
Masimo's first-quarter 2025 results continue to benefit from the strength in its Healthcare businesses despite tariff-related uncertainties.
Masimo to Present in the BofA Securities 2025 Health Care Conference
09:00am, Wednesday, 07'th May 2025
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025 at 4:20 p.m. Pac
Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript
10:15pm, Tuesday, 06'th May 2025
Masimo Corporation (NASDAQ:MASI ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Katie Szyman - Chief Executive Officer Micah Young - Executive Vice President, Chief Fina
Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates
07:10pm, Tuesday, 06'th May 2025
Masimo (MASI) came out with quarterly earnings of $1.36 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $0.77 per share a year ago.
Samsung Electronics says unit Harman acquires Masimo's audio business for $350 mln
05:06pm, Tuesday, 06'th May 2025
Samsung Electronics said on Wednesday its unit Harman International signed a deal to acquire U.S. firm Masimo's audio business for $350 million.
Masimo to Sell Consumer Audio Business to HARMAN International
04:10pm, Tuesday, 06'th May 2025
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced that it has entered into a definitive agreement to sell its Sound United consume
Masimo Reports First Quarter 2025 Results
04:10pm, Tuesday, 06'th May 2025
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced its financial results for the first quarter ended March 29, 2025. First Quarter 2025 Results From Continuing Operatio
Masimo to Sell Audio Business to Harman After Investor Outrage
04:00pm, Tuesday, 06'th May 2025
Samsung's Harman is set to pay around $350 million for the high-end audio-equipment maker.
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?
12:10pm, Monday, 05'th May 2025
MedTech companies' quarterly results are likely to reflect strength in customer demand. Let's see how FMS, MASI and CLOV are placed ahead of their earnings releases.
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
11:45am, Tuesday, 29'th Apr 2025
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha
